Loading data
IRWDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 296.15 m USD | 351.41 m USD | 442.74 m USD | 410.6 m USD | 413.75 m USD |
| Research and development expense | 95.14 m USD | 111.42 m USD | 1.1 bn USD | 44.27 m USD | 70.41 m USD |
| Selling, general and administrative expense | 82.26 m USD | 144.27 m USD | 158.31 m USD | 115.99 m USD | 111.13 m USD |
| Operating profit | 98.5 m USD | 93.12 m USD | -945.43 m USD | 250.34 m USD | 232.26 m USD |
| Interest expense | — | — | 21.63 m USD | 7.6 m USD | 31.15 m USD |
| Profit before tax | 70.03 m USD | 65.2 m USD | -948.07 m USD | 252.42 m USD | 200.66 m USD |
| Income tax expense | 46.01 m USD | 64.3 m USD | 83.49 m USD | 77.36 m USD | 338 m USD |
| Net income (reported basis) | 24.02 m USD | 880 k USD | -1.03 bn USD | 175.07 m USD | 528.45 m USD |
| Net income attributable to common shareholders | 24.02 m USD | 880 k USD | -1 bn USD | 175.07 m USD | 528.45 m USD |
| Basic earnings per share | 0.15 USD/share | 0.01 USD/share | -6.45 USD/share | 1.13 USD/share | 3.26 USD/share |
| Diluted earnings per share | 0.15 USD/share | 0.01 USD/share | -6.45 USD/share | 0.96 USD/share | 3.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.